7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flesher, JW; Horn, J; Lehner, AF | 1 |
| Gopalakrishnakone, P; Ignacimuthu, S; Samy, RP | 1 |
2 other study(ies) available for 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Rapid induction of mammary cancer by repeated subcutaneous injection of the trans-3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in the female Sprague-Dawley rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Female; Injections, Subcutaneous; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley; Sarcoma; Solubility; Time Factors | 2005 |
Anti-tumor promoting potential of luteolin against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Oral; Animals; Anticarcinogenic Agents; Antioxidants; Body Weight; Catalase; Female; Glutathione Peroxidase; Lipid Peroxides; Luteolin; Mammary Neoplasms, Experimental; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Treatment Outcome | 2006 |